eMAR Updates - June 2026

These releases introduce new features and address bugs

Release Notes

eMAR Portal Update (v5.8.0) – 23rd June (Planned Scope)

This release introduces a new daily clash email report alongside business as usual improvements.

Daily clash email report: New scheduled email report is now available summarising medication clashes.
PRN workflow improvements: PRN follow-up actions are now recorded against a dedicated sibling task rather than the parent medication administration task.
New check-in screen – custom schedules: Fixes several issues affecting medications on custom patterns. The calendar now shows the correct dosage for each day of a custom schedule (including the final days of the pattern), and medications with a custom pattern and varying daily dosages can now be checked in.
New check-in screen – PRN protocols: Fixes an issue where PRN protocol values could be cleared when checking in medication dispensed by the pharmacy.
New check-in screen – low stock changes: Fixes an issue where changes to a medication's low-stock level were ignored unless the underlying drug ID also changed.
New check-in screen – reliability: Resolves a case where a check-in could partially save when an error occurred, leading to a mismatch between what the screen showed and what was saved.
New check-in screen – stop date display: Fixes incorrect stop dates appearing under medications and in stop warnings (for example, today's date being shown for a medication scheduled to stop on a future date).
Mandatory route of administration: Adds mandatory validation for route of administration in the medication details and new check-in screens.
MAR chart for custom 90-day patterns: Fixes an issue where the MAR chart failed to display administered medication on the correct day, and on future dates, for medications using a custom 90-day repeat pattern.
Portal and App alignment: Fixes an issue where scheduled medication rounds visible on the Portal were not reflecting on the eMAR App.
Allergies hover: Fixes a case where allergies showed "None" when hovering over the allergies tab on the schedule page, even when allergies were correctly synced from Nourish.
Proxy linking: Resolves an issue where a service user could have multiple active proxy links to patients.
Bulk audit witness prompt: Fixes an issue where the Bulk Audit flow did not prompt for a witness login, even when the "Witness for Bulk Audit" setting was enabled.
Portal UI tweaks: A range of small UI improvements across the Portal.

eMAR App Update (v2.7.0) – 7th July 2026 (Planned Scope)

This release focuses on business as usual improvements. Early Acccess release is planned for 30th June.

Stopped PRN Warning: PRN medications now appear as stopped in the app immediately after a stop is configured in the portal (rather than remaining available until the end of the day). By default, users receive a warning when attempting to administer a stopped PRN medication, although this can be configured to require an authorisation.
Default round timings: Restores default round timings for the Camascope 2.0 App to the standard 4-hour split.
Offline PRN sync: Resolves a rare edge-case issue where administering a PRN medication from two devices while offline could result in one administration being lost during sync. Both records are now correctly reconciled when the devices come back online.
"Last taken" accuracy: Fixes cases where the "Last taken" label could disappear or display an incorrect time, ensuring staff have reliable information before re-administering a medication.
QR scanner reliability: Fixes scanner failures when rotating the device between portrait and landscape, and resolves a separate issue where the scanner could fail to start.
MAR screen time display: Corrects the due time shown on the MAR screen after moving to the next round when the tablet is in portrait mode.
Re-login screen: Fixes a black screen that could appear when reopening the app after the 30-minute inactivity logout.
App responsiveness: Improves responsiveness on devices with large databases by moving heavy database queries off the main thread, reducing freezes and "App Not Responding" prompts.
Other: Additional stability fixes across medication administration workflows.

VIVALDI Social Care Study

Camascope has partnered with the VIVALDI Social Care Study, which aims to leverage existing data to better understand and reduce the impact of infections and outbreaks in care homes.

Participation requires no input from care providers. Once agreed, Camascope will securely share only NHS numbers with the VIVALDI Study, allowing researchers to gain an accurate understanding of the number of residents in care homes.

To register your interest, click the button below and fill out the form.